Message from the MD & CEO
Welcome to our first newsletter for 2020. For many it has been a challenging start to the year with bushfire and extreme weather events across the country and the arrival of the novel coronavirus in Australia. Nonetheless, we are moving ahead with our ambitious agenda for the MTP sector this year and look forward to working with many of you in the months ahead.
We’re getting ready for the next phase of our national Biomedical
Translation Bridge (BTB) program roadshow where we are hosting Information Sessions on Round 2 funding opportunities. Remember, we’re providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage.
So come along to Sydney, Adelaide, Brisbane and Westmead. There are still places available so register today.
Now in its second year, the MTPConnect podcast series is already up and running for 2020. The MTPConnect podcast team caught up with well-known West
Australian Professor Fiona Wood AO about her career journey as a burns specialist, researcher and innovator. We also just released an episode with Arthur Ong from Curve Tomorrow discussing digital health innovation and latest developments underpinning the future of health.
Next month, the MTPConnect WA Life Sciences Innovation Hub is partnering with CSIRO’s Ribit to host a forum for PhD students, early-to-mid-career researchers and post-graduates to connect with industry leaders in Perth. It’s an event all about careers possibilities and bringing together research and industry to accelerate growth of the MTP sector.
I would like to welcome new members of the MTPConnect team, Dr David Fox who has joined us as Senior Director
Sustainability, and is based in Newcastle; and Rebekah Craggs as Stakeholder Engagement Coordinator WA. We also welcomed a new Board member, Alex Fowkes who has been appointed as a Non-Executive Director, and will be based in Queensland.
To stay up to date with all the latest news and events, follow us on Twitter - @DrDanGrant and @MTPConnect_AUS - and don't forget to subscribe to our podcast series.
And finally, if you are interested in following updates on Australia’s response to the coronavirus I encourage you to follow the Department of Health.
Dr Dan Grant
Managing Director & CEO
MTPConnect & Industry News
Alex Fowkes Joins MTPConnect Board
MTPConnect is pleased to announce the appointment of Alex Fowkes as a Non-Executive Director. Mr Fowkes was most recently the Chief Strategy Officer for WuXi NextCODE, a genomic information company, based in Singapore and is now returning to Australia. As a life science executive, he is an experienced leader and thought partner for life science strategy, commercial operations and business development.
Download our FY2019 Annual Report
This Annual Report is a chance to look back over not just the last twelve months, but the accumulated impact of nearly four years of a coordinated, industry-led approach to promoting the growth of this sector that is central to Australia’s future health and prosperity.
Introducing Dr David Fox – Senior Director Sustainability
MTPConnect is excited to announce the appointment of Dr David Fox as Senior Director of Sustainability starting this month. David will be based in Newcastle, NSW and will work with Managing Director & CEO Dr Dan Grant and Chief Operating Officer Stuart Dignam on forward-looking strategies for sector growth.
Introducing Rebekah Craggs – Stakeholder Engagement Coordinator WA
MTPConnect is excited to announce the appointment of Rebekah Craggs as our Stakeholder Engagement Coordinator WA, starting this month based at the Harry Perkins Institute of Medical Research in Perth.
- Biotech Dispatch covered Alex Fowkes appointment to the MTPConnect Board
- Melbourne scientists from the Peter Doherty Institute for Infection and Immunity were the first to grow and share novel coronavirus
- Listen to our podcast featuring Fiona Wood AO
- Subscribe to the new Medical Research Future Fund (MRFF) monthly newsletter to stay in touch with the latest developments and grant opportunities
- Check out the leadership change at the Department of Health
- The Australian Government announced an investment of $5 million in lung cancer research
Australian Government announced a $2 million Community STEM Grants Maker Program
- Researchers at RMIT University have used liquid metals to develop a new bacteria-destroying technology that could help address the challenge of antibiotic resistance
- Congrats to Navi Medical Technologies, who were awarded $400K by federal government to continue its work developing and testing its groundbreaking neoNAV product
- RMIT is part a group of researchers from across the globe developing a new therapy that aims to see if stem cells can be used to regenerate the brain
damage caused by premature birth
Join the City of Melbourne's Business Mission to China and
Submit an EOI to the UprAsia Program
Apply to the MedTech Actuator's Accelerator Program
Apply for the Medical Device Commercialisation Training Program
Submit an EOI to the WA BRIGHT Innovate in Digital
Submit an EOI to the 2020 BridgeTech Program
Apply to the 2020 Bridge Program
Submit your nominations for BioMelbourne Network's 2020 Women in Leadership Awards
Apply for the NHMRC's Global Alliance for Chronic
Diseases: Cancer Prevention
ANDHealth invites you to complete its survey to identify gaps, challenges & opportunities in digital health commercialisation
Enter the MRFF Tackling AMR and DR-TB Grant Opportunity
Submit for the MRFF Cardiovascular Health Mission
Enter MRFF – Clinical Trials Activity – RCRDUN Initiative – 2019 Rare Cancers, Rare Diseases and Unmet Need Grant
Apply to the MRFF – Clinical Trials Activity – RCRDUN Initiative – 2019 Reproductive Cancers Grant Opportunity
Share your innovation story to ge maker's #AUSInnovates platform
- MRCI have put a call out for volunteers for a research study on a vaccine against meningococcal type A,C,W,Y infections in healthy adults between 18 and 40 years
- Volunteer to participate in the Murdoch Children's Research Institute Genetics of Stuttering Study
3 February 2020 - Sydney Biomedical Translation Bridge Program Round 2 Information Session
5 February 2020 - Adelaide Biomedical Translation Bridge Round 2 Information Session
5 February 2020 - An introduction to Active MedTech - from concept to reality, NSW Active
MedTech Community, Webinar
6 February 2020 - Hot or Not: Trends for 2020, BioMelbourne Network, Melbourne
10-11 February 2020 - SYMPOSIUM - How Medical Device Interoperability, Safety and Security Will
Change Healthcare, Flinders University, Adelaide
12 February 2020 - Brisbane Biomedical Translation Bridge Program Round 2 Information Session
12 February 2020 - Regulatory requirements for Active Medical Devices, NSW Active MedTech
18 February 2020 - VIC BioCheers, AusBiotech, Melbourne
19 February 2020 - Obtaining grants to support your MedTech journey, NSW Active MedTech
19 February 2020 -Westmead Biomedical Translation Bridge Program Round 2 Information Session
24-26 February 2020 - B.R.I.G.H.T Innovate 3-Day Workshop, ANDHealth, Melbourne
To see what industry events are happening near you in 2019, visit our events page.
Are you are hosting an event? Share with the MTP sector by emailing: firstname.lastname@example.org
Pictured: Victorian Minister for Jobs, Trade, Innovation, Sport, Tourism, Major Events & Racing Hon. Martin Pakula MP opening The MedTech Actuator's 2019 Showcase in Melbourne.
Case Study Showcase: MedTech Start-Ups Have Talent
Start-up accelerator The MedTech Actuator has formed a collaboration with venture capital firm Artesian Ventures to create new growth opportunities for medtech start-ups. Funded as part of MTPConnect's Project Fund Program, the MedTech Actuator has achieved great outcomes, creating 55 new jobs and training over 1,000 innovators in less than 18 months. Read more.
Want to showcase your great work? Email email@example.com to submit a case study.
Sector Profile: Perth Blood Institute
The Perth Blood Institute (PBI) is a medical research institute specialising in blood disorders, including haemophilia, deep vein thrombosis, leukaemia, myeloma and lymphoma. PBI conducts medical research into blood disorders, including their causes, prevention and treatment options; facilitates access to high quality clinical trials for people affected by blood disorders; and
improves the provision of information about blood disorders to patients and their families. Learn more in our Sector Directory.
List your organisation on the MTPConnect Sector Directory.